Simon Ashwell

500 total citations
14 papers, 384 citations indexed

About

Simon Ashwell is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Simon Ashwell has authored 14 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Surgery and 1 paper in Molecular Biology. Recurrent topics in Simon Ashwell's work include Diabetes Management and Research (7 papers), Diabetes Treatment and Management (6 papers) and Pancreatic function and diabetes (4 papers). Simon Ashwell is often cited by papers focused on Diabetes Management and Research (7 papers), Diabetes Treatment and Management (6 papers) and Pancreatic function and diabetes (4 papers). Simon Ashwell collaborates with scholars based in United Kingdom, United States and Australia. Simon Ashwell's co-authors include P. D. Home, Philip Home, Umesh Dashora, Elke Witthaus, Clare Bradley, Stephanie A. Amiel, S.D. Shutler, David Hepburn, R. W. Bilous and Simon Heller and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetologia.

In The Last Decade

Simon Ashwell

12 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Ashwell United Kingdom 9 361 199 116 29 21 14 384
Saud Alsifri Saudi Arabia 9 336 0.9× 122 0.6× 137 1.2× 29 1.0× 18 0.9× 26 398
Holly Tschirhart Canada 5 289 0.8× 233 1.2× 79 0.7× 51 1.8× 8 0.4× 6 345
Lise Brøndsted Denmark 5 343 1.0× 222 1.1× 99 0.9× 32 1.1× 13 0.6× 8 432
M. Bogoev Denmark 6 405 1.1× 194 1.0× 130 1.1× 49 1.7× 6 0.3× 10 463
Molly McElwee-Malloy United States 3 343 1.0× 209 1.1× 190 1.6× 12 0.4× 10 0.5× 6 394
I. M�hlhauser Germany 3 294 0.8× 77 0.4× 116 1.0× 19 0.7× 41 2.0× 3 340
Pauline Schaepelynck France 12 275 0.8× 165 0.8× 137 1.2× 11 0.4× 6 0.3× 21 333
М. А. Коваренко Russia 6 283 0.8× 134 0.7× 102 0.9× 40 1.4× 18 0.9× 15 337
Helen Partridge United Kingdom 7 308 0.9× 200 1.0× 51 0.4× 70 2.4× 10 0.5× 16 333
Paul B. Madden United States 4 273 0.8× 145 0.7× 148 1.3× 8 0.3× 11 0.5× 6 317

Countries citing papers authored by Simon Ashwell

Since Specialization
Citations

This map shows the geographic impact of Simon Ashwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Ashwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Ashwell more than expected).

Fields of papers citing papers by Simon Ashwell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Ashwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Ashwell. The network helps show where Simon Ashwell may publish in the future.

Co-authorship network of co-authors of Simon Ashwell

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Ashwell. A scholar is included among the top collaborators of Simon Ashwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Ashwell. Simon Ashwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
3.
Awadelkareem, Abuzar, et al.. (2022). Pheochromocytoma masquerading as acute coronary syndrome. Endocrine Abstracts.
4.
Adams, George W., et al.. (2020). Microbiological evaluation of resection margins of the infected diabetic foot ulcer. Diabetic Medicine. 38(4). e14440–e14440. 6 indexed citations
5.
Gan, Earn H, Anna L. Mitchell, Lorna C Gilligan, et al.. (2019). Residual Adrenal Function in Autoimmune Addison’s Disease—Effect of Dual Therapy With Rituximab and Depot Tetracosactide. The Journal of Clinical Endocrinology & Metabolism. 105(4). e1250–e1259. 15 indexed citations
6.
Ullah, Arif, et al.. (2012). The cost, efficacy and safety of Omnitrope compared with Genotropin in adults with growth hormone deficiency. 28. 3 indexed citations
7.
Dashora, Umesh, Simon Ashwell, & P. D. Home. (2009). An exploratory study of the effect of using high‐mix biphasic insulin aspart in people with type 2 diabetes. Diabetes Obesity and Metabolism. 11(7). 680–687. 10 indexed citations
8.
9.
Dashora, Umesh, Latika Sibal, Simon Ashwell, & P. D. Home. (2007). Insulin glargine in combination with nateglinide in people with Type 2 diabetes: a randomized placebo‐controlled trial. Diabetic Medicine. 24(4). 344–349. 12 indexed citations
10.
Ashwell, Simon, Stephanie A. Amiel, R. W. Bilous, et al.. (2006). Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross‐over trial in people with Type 1 diabetes. Diabetic Medicine. 23(3). 285–292. 87 indexed citations
11.
Ashwell, Simon, et al.. (2006). Twice‐daily compared with once‐daily insulin glargine in people with Type 1 diabetes using meal‐time insulin aspart. Diabetic Medicine. 23(8). 879–886. 89 indexed citations
12.
Ashwell, Simon, et al.. (2005). Optimal timing of injection of once‐daily insulin glargine in people with Type 1 diabetes using insulin lispro at meal‐times. Diabetic Medicine. 23(1). 46–52. 42 indexed citations
13.
Home, Philip & Simon Ashwell. (2002). An overview of insulin glargine. Diabetes/Metabolism Research and Reviews. 18(S3). S57–S63. 19 indexed citations
14.
Samaras, Katherine, et al.. (1997). Will older sedentary people with non-insulin-dependent diabetes mellitus start exercising? A health promotion model. Diabetes Research and Clinical Practice. 37(2). 121–128. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saud Alsifri Breakdown of academic impact, for papers by Holly Tschirhart Breakdown of academic impact, for papers by Lise Brøndsted Breakdown of academic impact, for papers by M. Bogoev Breakdown of academic impact, for papers by Molly McElwee-Malloy Breakdown of academic impact, for papers by I. M�hlhauser Breakdown of academic impact, for papers by Pauline Schaepelynck Breakdown of academic impact, for papers by М. А. Коваренко Breakdown of academic impact, for papers by Helen Partridge Breakdown of academic impact, for papers by Paul B. Madden
Rankless by CCL
2026